Fortitude Family Office, LLC

Family Office

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1950506 SCOTTSDALE, AZ

Position in REGN

as of Mar 31, 2026 · filed Apr 16, 2026 Compact

Position Value

$19,316

+$10,826 QoQ

Shares Held

+127.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Fortitude Family Office, LLC holds $460,072 across 122 Biotechnology names. REGN ranks #4 (4.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	522	$172,714
2	VRTX	Vertex Pharmaceuticals Inc / Ma	75	$33,490
3	RVMD	Revolution Medicines, Inc.	296	$28,786
4	REGN	Regeneron Pharmaceuticals, Inc. This page	25	$19,316
5	JAZZ	Jazz Pharmaceuticals plc	60	$11,343
6	CMPX	Compass Therapeutics, Inc.	1,915	$10,130
7	TERN	Terns Pharmaceuticals, Inc.	192	$10,122
8	INCY	Incyte Corp	101	$9,506

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$19,316	25	+127.3%	Shares	Sole	2026-04-16
2025-12-31	$8,490	11	-26.7%	Shares	Sole	2026-01-15
2025-09-30	$8,434	15	-16.7%	Shares	Sole	2025-10-17
2025-06-30	$9,450	18	-66.7%	Shares	Sole	2025-07-15
2025-03-31	$34,248	54	0.0%	Shares	Sole	2025-04-16
2024-12-31	$38,465	54	-3.6%	Shares	Sole	2025-01-10
2024-09-30	$58,869	56	0.0%	Shares	Sole	2024-10-25
2024-06-30	$58,857	56	+60.0%	Shares	Sole	2024-07-10
2024-03-31	$33,687	35	0.0%	Shares	Sole	2024-04-11
2023-12-31	$30,740	35	—	Shares	Sole	2024-01-12
No filing history on record for this holder in this stock.